Oculis
stage results stage trial next step commence stage of phase program to support filing of for treatment | Oculis
Company
Deck Type
Deck date
June 2023
Slide
21 of 39
Similar slides by Oculis
See diffirences between slides (animation)
Investor Presentation
April 2024
positive phase stage results risking stage trial next step complete stage of phase program to support filing of for treatment lis | Oculis
Investor Presentation
July 2023
positive and solid stage next step continue diamond program with full weeks trials to support filing of for treatment | Oculis
Results
May 2023
stage recap trial objectives met results validated loading and maintenance regimen to optimize efficacy potential in with robust statistical significance met all functional and clinical benefit in a robust statistically superior manner in month trial no unexpected safety findings observed next step commence stage of program to support filing of for treatment | Oculis
Related slides by other companies
Direct Biologics
SPAC
October 2022
phase clinical trial demonstrated positive results | Direct Biologics
Immatics
Investor Presentation
November 2023
phase clinical trial to evaluate targeting | Immatics
ATAI
Investor Presentation
October 2023
program status phase expected in clinical trial design results | ATAI
Minerva
IPO
October 2021
clinical trial results less | Minerva
Other recent decks by Oculis
See all presentations (7 decks)
Investor Presentation
April 2024
Results
August 2023
Investor Presentation
July 2023
Results
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights